Sulforaphane: Its Origin, Action, and Possible Therapeutic Value
Sulforaphane is a small, naturally occurring compound produced when certain cruciferous vegetables — especially broccoli sprouts — are damaged (for example by chopping or chewing). In the plant it exists as a precursor called glucoraphanin; an enzyme called myrosinase converts glucoraphanin into active sulforaphane when the plant tissue is disrupted. Because broccoli sprouts contain far higher levels of the precursor than mature broccoli, they are commonly used in research and supplements aimed at delivering sulforaphane. (PMC)
At the cellular level, sulforaphane works mainly by switching on the body’s “detox and antioxidant” defenses. It activates a master regulatory protein called Nrf2, which then increases the production of dozens of cytoprotective enzymes (often called phase II detoxification enzymes and antioxidant proteins). Through Nrf2 activation and related pathways, sulforaphane reduces oxidative stress and inflammation, improves the removal of potential carcinogens, and can influence gene expression and even epigenetic marks that affect how cells respond to damage. These mechanisms are the biological rationale for much of the interest in sulforaphane. (PMC)
Because those mechanisms are broadly protective, researchers have tested sulforaphane in many contexts. In laboratory and animal studies it shows anticancer effects (slowing tumour growth, enhancing detoxification of carcinogens), neuroprotective actions (reducing inflammation and protecting neurons), and beneficial effects on metabolic health (improving markers of insulin resistance and liver function). These preclinical results are consistent and biologically plausible, which is why clinical researchers have pursued human trials. (PMC)
Clinical evidence in people is promising but not yet definitive. Small human trials have shown that sulforaphane-rich preparations can activate Nrf2 in tissues and change biomarkers of oxidative stress and detoxification within days, and several pilot or phase-II studies have reported improvements in specific conditions — for example, small randomized trials of broccoli-sprout–derived sulforaphane reported measurable symptom benefits in some people with autism spectrum disorder and biomarker changes in trials of cancer prevention and metabolic health. However, many clinical studies are small, differ in the preparations and doses used, and need independent replication before firm clinical recommendations can be made. (ClinicalTrials)
Two practical points affect how well sulforaphane works in the real world. First, the amount of active sulforaphane produced depends heavily on how the vegetable is prepared and on the presence of active myrosinase; cooking at high heat destroys the enzyme and reduces conversion, whereas chopping and allowing a short rest before light cooking preserves more activity. Second, individual differences in gut bacteria influence how efficiently the precursor is converted to sulforaphane in the digestive tract, so the same serving can produce quite different blood levels in different people. These sources of variability help explain why trials of whole-food preparations and supplements sometimes give mixed results. (PMC)
Safety appears acceptable at doses used in most clinical studies, with gastrointestinal upset being the most commonly reported side effect; long-term safety and optimal dosing are still under study. Because sulforaphane modulates important cellular pathways, people taking prescription drugs, those with specific health conditions, pregnant or breastfeeding people, or anyone considering high-dose supplements should discuss this with a clinician before starting use. Overall, sulforaphane is a compelling, biologically plausible nutraceutical: strong preclinical data and promising early human trials support further research, but larger and more rigorous clinical trials are needed to establish clear therapeutic roles, standardize dosing, and identify which patients are most likely to benefit. (PMC)
(Source : ChatGPT)
/image%2F3334645%2F20201111%2Fob_fd07bb_sans-titre-1.jpg)